Inna V. Markova

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Spectroscopic Study of Methylene Blue Interaction with Coenzymes and Its Effect on Tumor Metabolism2025
• Study of methylene blue photodynamic activity on erythrocyte suspensions in vitro2025
• Simultaneous Application of Methylene Blue and Chlorin e6 Photosensitizers: Investigation on a Cell Culture2025
• The Combined Use of Methylene blue and Chlorin E6 Photosensitizers for Photodynamic Therapy and Correction of the Tumor Microenvironement2024
• Metabolic stress of tumor microenvironment during photothermal therapy: activation of an immune antitumor response2024
• Bleeding rate reduction in children with hemophilia A and inhibitors treated with emicizumab in the real-world clinical setting2022
• Inotuzumab ozogamicin in infants and young children with relapsed or refractory acute lymphoblastic leukaemia: a case series2021 · аннотациясвернуть

  Summary No data on inotuzumab ozogamicin (InO) in infant acute lymphoblastic leukaemia (ALL) have been published to date. We collected data internationally on infants/young children (<3 years) with ALL treated with InO.…

• Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients2019 · аннотациясвернуть

  About 70–80% of Hodgkin lymphoma patients can be cured with first-line chemotherapy [1]. In case of relapsed and refractory classical Hodgkin lymphoma (r/r cHL), second-line treatment and high-dose...